(Total Views: 540)
Posted On: 06/04/2019 1:46:45 PM
Post# of 30015
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
Amarantus to Present at 9th Annual LD Micro Invitational Conference
Download as PDF
JUNE 04, 2019
New York, NY, June 04, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Amarantus Bioscience Holdings, Inc. (OTC Pink: AMBS) (the “Company,” or AMBS), a US-based JLABS-alumnus biotechnology holding company developing first-in-class orphan neurologic, regenerative medicine and ophthalmic therapies and diagnostics through its subsidiaries, today announced that President & CEO Gerald Commissiong will make a corporate presentation at the 9th Annual LD Micro Invitational Conference. The presentation will be at 8:20am Pacific time on Wednesday, June 5th, 2019 in Track 5 at the Luxe Sunset Bel Air Hotel
Download as PDF
JUNE 04, 2019
New York, NY, June 04, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Amarantus Bioscience Holdings, Inc. (OTC Pink: AMBS) (the “Company,” or AMBS), a US-based JLABS-alumnus biotechnology holding company developing first-in-class orphan neurologic, regenerative medicine and ophthalmic therapies and diagnostics through its subsidiaries, today announced that President & CEO Gerald Commissiong will make a corporate presentation at the 9th Annual LD Micro Invitational Conference. The presentation will be at 8:20am Pacific time on Wednesday, June 5th, 2019 in Track 5 at the Luxe Sunset Bel Air Hotel
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)